Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic Cell Immunotherapy of Metastatic Melanoma - A Phase I Trial

NCT00003792 is registered in ClinicalTrials.gov with Baylor Health Care System as lead sponsor.

NCT NCT00003792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic Cell Immunotherapy of Metastatic Melanoma - A Phase I Trial
Lead sponsor
Baylor Health Care System
Phase
Phase 1
Overall status
Completed
Start date
April 30, 1999
Completion date
October 31, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)